SciCross joins ABIRISK IMI project

SciCross has joined the IMI ABIRISK consortia, focused on understanding the mechanisms and consequences of drug immunogenicity of biopharmaceuticals. The project runs until November 2017 and has a total budget of approximately 33M euro.